How Much Did Lumeda Raise?
Funding & Key Investors

Lumeda has secured $4.3M in total capital, with its most recent financing round bringing in $4.3M. This major strategic investment underscores the company's progress in advancing photodynamic therapy (PDT) for thoracic malignancies.

What is Lumeda?

Lumeda
ManufacturingMedical Devices & EquipmentHealthcare Software

Lumeda is a medical technology company focused on revolutionizing the treatment of non-small cell lung cancer (NSCLC) and other thoracic malignancies through advanced photodynamic therapy (PDT). The company leverages cutting-edge photonics and proprietary software to automate and refine PDT light delivery, aiming to enhance treatment efficacy, simplify clinical application, and improve treatment planning. With a multidisciplinary team possessing decades of experience in the photonics industry, including systems engineering and new technology commercialization, Lumeda is dedicated to pioneering advancements in PDT for better patient outcomes.

How much funding has Lumeda raised?

Lumeda has raised a total of $4.3M across 1 funding round:

2021

Series A

$4.3M

Series A (2021): $4.3M with participation from Connecticut Innovations and Cycle Venture Partners

Key Investors in Lumeda

Connecticut Innovations

Connecticut Innovations (ctinnovations.com) is Connecticuts strategic venture capital arm and quasipublic investment agency, providing equity and debt financing, strategic guidance, and connections to help innovative, growing companies in the state scale, with dedicated funds for sectors like AI/quantum, climate tech, and biosciences.

Cycle Venture Partners

Cycle Venture Partners is an investment firm that provides capital for companies. Further details on their specific investment focus are not readily available.

What's next for Lumeda?

The recent major strategic investment signals a significant growth phase for Lumeda, likely enabling the company to scale its operations, further develop its technology, and expand its market reach. This capital infusion is expected to accelerate the commercialization of its automated PDT light delivery system, positioning Lumeda to capture a larger share of the oncology treatment market. Future strategic initiatives may involve clinical trial expansions, regulatory approvals, and partnerships to broaden the application of its innovative PDT solutions.

See full Lumeda company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Glass & ClayManufacturingBuilding MaterialsRetailHome Improvement & Hardware Retail
Industrial Machinery & EquipmentManufacturingHome Improvement & Hardware RetailRetail
Food & BeverageManufacturingRetailConvenience Stores, Gas Stations & Liquor Stores
ManufacturingMedical Devices & EquipmentAuctionsOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)Retail

Frequently Asked Questions Regarding Lumeda Financial Insights

What are the most recent funding rounds that Lumeda has completed, and what were the funding rounds?
Lumeda has recently completed 1 funding rounds: Series A on Apr 8, 2021.
What is the total amount of funding Lumeda has raised to date?
Lumeda has raised a total of $4.3M in funding to date.
How many funding rounds has Lumeda completed?
Lumeda has completed 1 funding rounds.
How much funding did Lumeda raise in its most recent funding round?
Lumeda raised $4.3M in its most recent funding round.
Who are the lead investors in Lumeda's latest funding round?
The lead investor in Lumeda's latest funding round was Connecticut Innovations. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Lumeda's history?
The largest funding round in Lumeda's history was $4.3M.
See more information about Lumeda